FDA Drug Recalls

Recalls / Class II

Class IID-1055-2017

Product

Ibuprofen Tablets, USP 600 mg, 500-count bottle (Capsule Shaped), Rx only, Manufactured for: Time Cap Labs, Inc., 7 Michael Avenue Farmingdale, NJ 11735, USA, Manufactured by: Marksans Pharma Ltd. Plot No. L-82, L-83 Verna Indl. Estate, Verna, Goa-403 722, India, NDC 49483-603-50

Brand name
Ibuprofen
Generic name
Ibuprofen
Active ingredient
Ibuprofen
Route
Oral
NDCs
49483-602, 49483-603, 49483-604
FDA application
ANDA090796
Affected lot / code info
Lot #: HN7003

Why it was recalled

Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.

Recalling firm

Firm
Time-Cap Laboratories, Inc.
Manufacturer
TIME CAP LABORATORIES, INC
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
7 Michael Ave, N/A, Farmingdale, New York 11735-3921

Distribution

Quantity
1,980 bottles
Distribution pattern
Nationwide U.S.A.

Timeline

Recall initiated
2017-06-16
FDA classified
2017-08-03
Posted by FDA
2017-08-09
Terminated
2020-05-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1055-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Ibuprofen · FDA Drug Recalls